CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1 - 10 of 826
Study Number Lead Group Study Title CIRB Study Status
A211701 Alliance A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort Cancer Prevention and Control CIRB Available to Open
MAY2016-08-01 CLO-Mayo Clinic A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer Cancer Prevention and Control CIRB Available to Open
EAZ171 ECOG-ACRIN Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women Cancer Prevention and Control CIRB Available to Open
EAQ161CD ECOG-ACRIN Biomarker Testing in Common Solid Cancers: An Assessment of Current Practices in Precision Oncology in the Community Setting Cancer Prevention and Control CIRB Completed
S1703 SWOG Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer Cancer Prevention and Control CIRB Available to Open
MDA2014-04-01 CLO-MD Anderson Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II ER-Positive Breast Cancer: a Randomized Presurgical Trial Cancer Prevention and Control CIRB Available to Open
EA2185 ECOG-ACRIN Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs Cancer Prevention and Control CIRB Available to Open
NWU2015-06-03 CLO-Northwestern University Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer Cancer Prevention and Control CIRB Available to Open
MDA2016-08-02 CLO-MD Anderson A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer Cancer Prevention and Control CIRB Available to Open
A221504 Alliance A Randomized; Double-Blind; Placebo-Controlled Pilot Study of an Oral; Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma) Cancer Prevention and Control CIRB Available to Open
Displaying 1 - 10 of 826